CMS advises Synlab on add-on acquisition of two Italian lab service providers

Stuttgart – Lab service provider Synlab has acquired the two Italian lab companies Fleming Labs and Centro Diagnostico San Nicolò from French clinic operator Générale de Santé. The two firms employ a total of 550 people at four lab locations.

A cross-border team from CMS Hasche Sigle and CMS Adonnino Ascoli & Cavasola Scamoni advised Synlab on all aspects of the acquisition, with Dr Udo Simmat, partner at CMS Germany, and Pietro Cavasola, partner at CMS Italy, taking the lead role.

Synlab is a portfolio company owned by global private equity firm BC Partners. In 2009, an international CMS team led by Dr Udo Simmat advised BC Partners on the acquisition of leading lab service providers Synlab (Germany) and FutureLAB (Austria). As part of this deal, CMS developed a contractual solution covering a total of 18 jurisdictions within Europe and beyond. “We hit the ground running in the major European countries thanks to the unique collaborative capabilities of the international CMS locations,” says private equity expert Simmat.

The purchase of Fleming Labs and Centro Diagnostico San Nicolò is an add-on acquisition for lab firm Synlab. This new acquisition means that the Augsburg-based company is represented in 21 countries and gains its first presence in the Italian market.

Advisers CMS Hasche Sigle:
Dr Udo Simmat, Private Equity (Lead Partner)
Dr Claus-Peter Fabian, M&A
Dr Christoph Lächler, M&A
Julia Runge, Banking & Finance
Dr Harald Kahlenberg, Antitrust

Advisers CMS Adonnino Ascoli & Cavasola Scamoni (Italy):
Pietro Cavasola (Lead Partner Italy)
Serena Carroli, Corporate/M&A
Matteo Ciminelli, Corporate/M&A
Paolo Scarduelli, Antitrust

Contact:
Dr Udo Simmat
+49 711 9764 363
Udo.Simmat@cms-hs.com